Read this company snapshot
Daily valuation snapshot
Oncolytics Biotech, Inc. Common Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.56
- Market capitalization (USD)
- $71,023,351.29
- Price / earnings (TTM)
- Not reported
- Price / book
- Not reported
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ONCY in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ONCY in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing ONCY with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.56 |
| Market capitalization (USD) | $71,023,351.29 |
| Price / earnings (TTM) | Not reported |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read ONCY's valuation metrics
Company size
Oncolytics Biotech, Inc. Common Shares's recorded market capitalization is $71,023,351.29. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Oncolytics Biotech, Inc. Common Shares with Aurora
Use the snapshot above to ask a specific question about ONCY. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ONCY's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.